Philippe Motté

Philippe Motté

Gründer bei Celestial Consulting & Coaching

64 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Philippe Motté

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 8
1
Holding Company Biotechnology 1
Académie nationale de Pharmacie
1
Private Company 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Philippe Motté

UnternehmenSektorVerknüpfte PersonenHauptposition
CELGENE Biotechnology

Katherine Kalin

Corporate Officer/Principal

MERCK KGAA Pharmaceuticals: Major

Steven Hildemann

Chief Tech/Sci/R&D Officer

BAYER AG Pharmaceuticals: Major

Joseph Scheeren

Corporate Officer/Principal

IPSEN Pharmaceuticals: Major

Steven Hildemann

Chief Tech/Sci/R&D Officer

Financial Conglomerates

Katherine Kalin

Director/Board Member

Summit Foundation

Katherine Kalin

Director/Board Member

STALLERGENES Pharmaceuticals: Major

Christian Chavy

Chief Executive Officer

University of Freiburg College/University

Steven Hildemann

Doctorate Degree

Investment Managers

Philippe Moons

Private Equity Analyst

Chemicals: Specialty

Christian Chavy

Chief Executive Officer

College/University

Joseph Scheeren

Corporate Officer/Principal

Investment Banks/Brokers

Jean-François Tiné

Corporate Officer/Principal

University of Durham College/University

Katherine Kalin

Undergraduate Degree

Medical Distributors

Christian Chavy

Chief Operating Officer

Pharmaceuticals: Major

Christian Chavy

Sales & Marketing

Pharmaceuticals: Major

Christian Chavy

Corporate Officer/Principal

Medical/Nursing Services

Christian Chavy

Director/Board Member

University of Leiden College/University

Joseph Scheeren

Doctorate Degree

ABIONYX PHARMA Pharmaceuticals: Major

Christian Chavy

Director/Board Member

ESSEC Business School College/University

Christian Chavy

Undergraduate Degree

Institut de Contrôle de Gestion College/University

Christian Chavy

Graduate Degree

Miscellaneous Commercial Services

Joseph Scheeren

Corporate Officer/Principal

Miscellaneous Commercial Services

Joseph Scheeren

Chairman

ATHERSYS, INC. Biotechnology

Katherine Kalin

Director/Board Member

Miscellaneous Commercial Services

Joseph Scheeren

Chief Executive Officer

Investment Managers

Christian Chavy

Director/Board Member

Miscellaneous Commercial Services

Philippe Moons

Director/Board Member

Pharmaceuticals: Major

Eric Baclet

President

Serono France SA

Christian Chavy

Chairman

Miscellaneous Commercial Services

Katherine Kalin

Corporate Officer/Principal

Pharmaceuticals: Major

Eric Baclet

Director/Board Member

Harvard Business School College/University

Katherine Kalin

Masters Business Admin

Medical/Nursing Services

Katherine Kalin

Director/Board Member

ESCP Europe College/University

Thomas Baetz

Undergraduate Degree

Genfit Pharmaceuticals SAS

Nathalie Huitorel

Corporate Officer/Principal

INVENTIVA Biotechnology

Alice Roudot-Ketelers

Chief Operating Officer

Pharmaceuticals: Major

Christian Chavy

Founder

Investment Managers

Thomas Baetz

Corporate Officer/Principal

Pharmaceuticals: Generic

Eric Baclet

Director/Board Member

SELLAS LIFE SCIENCES GROUP, INC. Pharmaceuticals: Major

Katherine Kalin

Director/Board Member

Miscellaneous Commercial Services

Joseph Scheeren

Director/Board Member

Universite Paris Cite College/University

Eric Baclet

Undergraduate Degree

Université De Lille College/University

Alice Roudot-Ketelers

Doctorate Degree

BARINTHUS BIOTHERAPEUTICS PLC Pharmaceuticals: Major

Joseph Scheeren

Director/Board Member

Statistik

International

Frankreich 17
Vereinigte Staaten 12
Vereinigtes Königreich 8
Deutschland 5
Schweiz 4

Sektoral

Health Technology 21
Consumer Services 11
Finance 7
Commercial Services 7
Health Services 3

Operativ

Director/Board Member 23
Corporate Officer/Principal 16
Independent Dir/Board Member 8
Undergraduate Degree 8
Chairman 5
  1. Börse
  2. Insiders
  3. Philippe Motté
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT